经桡动脉与经股动脉入路无闭合装置TACE随机试验
该随机试验纳入130例肝细胞癌TACE患者,比较经桡动脉与经股动脉入路(后者不使用血管闭合装置)的技术参数、安全性和患者满意度。结果显示两组技术成功率、造影剂剂量、透视时间、手术时间、辐射剂量、住院时间和总费用均无显著差异,不良事件发生率与严重程度也相似;但经桡动脉组在整体不适、如厕困难、进食或自理困难、行走困难及健康相关生活质量多个维度均显著优于经股动脉组,且更多患者愿意下次手术沿用当前入路(90.8% vs 24.6%,p<0.001)。
要点
- 经桡动脉入路TACE可早期下床活动,显著提高日常生活能力和健康相关生活质量。
- 两组技术参数和安全性无显著差异,但经桡动脉组患者满意度更高。
- 不使用闭合装置时,经桡动脉入路在生活质量和患者偏好上优于经股动脉入路。
诊断标准与关键数值
- 经桡动脉组与经股动脉组技术成功率、交叉率、造影剂剂量、透视时间、手术时间、空气比释动能、剂量面积乘积、住院时间和总费用均相似(所有p>0.05)。
- 两组不良事件发生率和严重程度相似(所有p>0.05)。
- 经桡动脉组整体不适、如厕困难、进食或自理困难、行走困难、总体健康、生理功能、生理职能、社会功能、心理健康和情感职能均优于经股动脉组(所有p<0.001)。
- 经桡动脉组更多患者愿意下次手术沿用当前入路(90.8% vs 24.6%,p<0.001)。
临床应用与阅片要点
- 在无血管闭合装置条件下,经桡动脉入路TACE可促进早期下床活动,改善患者日常生活能力和健康相关生活质量。
- 经桡动脉入路不增加手术时间、辐射剂量或造影剂用量,可作为经股动脉入路的替代选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare patient satisfaction, procedural variables, and safety with transradial access (TRA) and transfemoral access (TFA) in patients undergoing transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: From February 2019 to August 2021, 130 patients undergoing TACE for HCC were randomly allocated to the TRA (n = 65) or TFA (n = 65) group. Vascular closure devices were not used after TFA-TACE. All patients completed the post-catheterization questionnaire and 8-item Short-Form Health Survey 1 day after TACE.
RESULTS: Technical success rate, crossover rate, contrast agent dose, fluoroscopy time, procedure time, air kerma, dose-area product, length of hospital stay, and total cost were similar between the two groups (all p > 0.05). The incidence and severity of adverse events were also similar between the two groups (all p > 0.05). However, overall discomfort, difficulty going to the bathroom, difficulty feeding or self-caring, difficulty walking, general health, physical function, role physical function, social function, mental health, and role emotional function were better in the TRA group than in the TFA group (all p < 0.001). Consequently, more patients preferred the current access for their next procedure in the TRA group than in the TFA group (90.8% vs. 24.6%; p < 0.001).
CONCLUSION: In patients undergoing TACE for HCC, using TRA instead of TFA can improve patient satisfaction without compromising procedural variables and safety.
KEY POINTS: • Transradial access (TRA) enabled early ambulation after transarterial chemoembolization (TACE), resulting in significant increase in activities of daily living and health-related quality of life (HRQoL) compared to transfemoral access (TFA) when vascular closure devices were not used. • Procedural variables (contrast agent dose, fluoroscopy time, procedure time, air kerma, dose-area product, length of hospital stay, and total cost) were not significantly different between patients who received TRA-TACE and TFA-TACE. • The incidence and severity of adverse events were similar between patients who received TRA-TACE and TFA-TACE.
引用
- Zhang, Luo, Tsauo, et al. Transradial versus transfemoral access without closure device for transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized trial. Eur Radiol. 2022. PMID: 36018356. doi:10.1007/s00330-022-09038-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。